ChinaPeptides Co., Ltd is a renowned high-tech company in the peptide synthesis industry, offering custom peptides synthesis services with a wide variety of purity levels, scales, and modifications to meet diverse research needs. The company utilizes advanced technology, including automatic and manual peptide synthesizers, purification and analytical HPLC systems, and state-of-the-art technology to ensure high-quality products. Their standard stepwise solid phase peptide synthesis (SPPS) procedures, employing both Boc and Fmoc chemical synthesis techniques, are considered the current and best method in peptide synthesis. Every peptide undergoes rigorous testing by Mass spectrum and HPLC chromatogram, with the quality analysis data sheet provided to customers for transparency.
Founded in 2009 and headquartered in China, ChinaPeptides operates in the Biopharma and Biotechnology industries, offering services such as protein expression, antibody services, drug discovery services, and industrial synthetic biology products. With a comprehensive range of offerings and a commitment to delivering high-quality products, the company has carved a niche for itself in the market.
Currently, there is no public information available regarding the last investment and the associated investors for ChinaPeptides Co., Ltd. However, the company's strong presence in the industry and its dedication to technological advancement make it an intriguing prospect for potential investors looking to tap into the growing biotech and pharma sectors in China.
There is no investment information
No recent news or press coverage available for ChinaPepdies Co.,Ltd.